Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer

Acta Oncologica

Volumn 38, Issue 8, 1999, Pages 1011-1015

  Tas, Faruk ^a   Aydiner, Adnan ^b   Topuz, Erkan ^b   Camlica, Hakan ^b   Saip, Pinar ^b   Eralp, Yesim ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0033427694     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699432275     Document Type: Article

References (27)

1. Matthews MJ. Problems in morphology and behavior of bronchopulmonary malignant diseases. In: Israel L, Chahinian AP, eds. Lung cancer: natural history, prognosis, and therapy. New York: Academic Press, 1976: 23-62.
2. Ihde DC, Hansen HH. Staging procedures and prognostic factors in small cell carcinoma of the lung. In: Greco FS, Oldman RK, Bunn PA, eds. Small cell lung cancer. New York: Grune & Stratton, 1981: 261-83.
3. Abrams J, Doyle YA, Aisner J. Staging, prognostic features, and special considerations in small cell lung cancer. Semin Oncol 1988; 15: 261-77.
4. Ihde DC. Staging evaluation and prognostic factors in small cell lung cancer. In: Aisner J, ed. Lung cancer. New York: Churchill Livingstone, 1985: 241-68.
5. Crane JM, Nelson MJ, Ihde DC, et al. A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer. J Clin Oncol 1984; 2: 1017-24.
6. Giannone L, Johnson DH, Hande KR, Greco FA. Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 1987; 106: 386-9.
7. Van Hazel G, Scott M, Eagan RT. The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer 1983; 51: 33-7.
8. Maurer LH, Pajak TJ. Prognostic factors in small cell carcinoma of the lung. A cancer and leukemia group B study. Cancer Treat Rep 1981; 65: 767-74.
9. Dearing M, Steinberg S, Phelps R, et al. Outcome of patients with small cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol 1990; 8: 1042-9.
10. Livingstone RB, McCraken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. Chest 1982; 81: 208-11.
11. Mirvis SE, Whitley NO, Aisner J, Moody M, Whitacre M, Whitley JE. Abdominal CT in the staging of small cell carcinoma of the lung: incidence of metastases and effect of prognosis. AJR 1987; 148: 845-7.
12. Sagman U, Feld R, Evans WK, et al. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small cell lung cancer. J Clin Oncol 1991; 9: 954-61.
13. Kristjansen PE, Osterlind K, Hansen M. Detection of bone marrow relapse in patients with small cell carcinoma of the lung. Cancer 1986; 58: 2538-41.
14. Livingston RB, Trauth CJ, Greenstreet RL. Small cell carcinoma: clinical manifestations and behavior with treatment. In: Greco FA, Oldham RK, Bunn PA, eds. Small cell lung cancer. Orlando: Grune & Stratton, 1981: 285-300.
15. Albain KS, Crowley JJ, LeBlanc M, Livingstone RB. Determinants of improved outcome in small cell lung cancer. An analysis of the 2580 patients Southwest Oncology Group Data. J Clin Oncol 1990; 8: 1563-74.
16. Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. A report from the subcommittee for the management of lung cancer of the United Kingdom Coordinating Committee in Cancer Research. Br J Cancer 1990; 61: 597-604.
17. Spiegelman D, Maurer LH, Ware JH, et al. Prognostic factors in small cell carcinoma of the lung. An analysis of 1521 patients. J Clin Oncol 1989; 7: 344-54.
18. Sagman U, Maki E, Evans WK, et al. Small cell carcinoma of the lung. Derivation of a prognostic staging system. J Clin Oncol 1991; 9: 1639-49.
19. Lenhard RE, Woo AB, Abeloff MD. Predictive value of regression rates following chemotherapy of small cell carcinoma of the lung. Cancer Res 1983; 43: 3013-7.
20. Cohen MH, Makuch RW, Johnson-Early A, et al. Laboratory parameters as an alternative to performance status in prognostic stratification. Of patients with small cell lung cancer. Cancer Treat Rep 1981; 65: 187-95.
21. Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N. Pretreatment prognostic factors and scoring system in 407 small cell lung cancer patients. Int J Cancer 1987; 39: 146-9.
22. Siu LL, Shephard FA, Murray N, Feld R, Pater J, Zee B. Influence of age in the treatment of limited stage small cell lung cancer. J Clin Oncol 1996; 14: 821-8.
23. Wolf M, Holle R, Hans K, Drings P, Havemann K. Analysis of prognostic factors of 766 patients with small cell lung cancer: the role of sex as a predictor of survival. Br J Cancer 1991; 63: 986-92.
24. Johnson BE, Steinberg SM, Phelps R, Edison M, Veach SR. Ihde DC. Female patients with small cell lung cancer live longer than male patients. Am J Med 1988; 85: 194-6.
25. Osterlind K, Hansen HH, Hansen M, Dombernowsky P, Andersen PK. Long-term disease-free survival in small cell carcinoma of the lung. A study of clinical determination. J Clin Oncol 1986; 4: 1307-13.
26. Souhami RL, Bradbury I, Geddes DM, Spiro SG, Harper PG, Tobias JS. Prognostic significance of laboratory parameters researched at diagnosis in small cell cancer of the lung. Cancer Res 1985; 45: 2878-82.
27. Ihde DC, Makuch RW, Carney DN, et al. Prognostic implications of stage of disease and site of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 1981; 123: 500-7.